ArticleInsights into imaging2026
Commercial large language models for oral cavity cancer staging using descriptive pre-treatment MRI reports: ready for standalone use in clinical practice?
Article in Insights into imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesMRI is used for staging head and neck cancer (HNC), but assigning T- and N-category criteria requires specialised expertise, and so many institutions offer only descriptive MRI reports. This study assessed potentials of commercial large language models (LLMs) to stage oral cavity cancer (OCC) using descriptive MRI reports and compared their accuracy with human experts. MATERIALS AND
methods104 eligible MRI reports were processed by five commercial LLMs (ChatGPT5.4, ChatGPT5.0, ChatGPT4.1, Gemini3.1 and DeepSeekV3.2). T- and N-categories, and overall stage were extracted from outputs of the LLMs. MRI reports were also staged by two multidisciplinary team (MDT) members. Accuracies of the LLMs and MDT members for cancer staging were assessed against the reference staging standard and compared using the McNemar test.
resultsThe LLMs showed accuracy of 54.8-76.0% for T-categorisation, 63.5-88.5% for N-categorisation, and 53.8-80.8% for overall stage. Compared with DeepSeekV3.2, ChatGPT and Gemini3.1 showed significantly higher accuracy (p ≤ 0.001), except for Gemini3.1 for T-categorisation (p = 0.07). No differences in accuracy for staging between ChatGPT versions and between them and Gemini3.1 (p = 0.08 to > 0.99). MDT members showed accuracy of 74.0-76.9% for T-categorisation, 76.9-77.9% for N-categorisation and 68.3-71.2% for overall stage. The tested LLMs did not consistently outperform MDT members for staging.
conclusionVariable tested LLM performance in staging OCC from descriptive MRI reports suggested that they are not suitable as standalone staging tools. Additionally, Low MDT staging accuracy highlighted the need for structured reports that include clinical cancer staging to facilitate MDT assessment, thus potentially ensuring optimised disease management. KEY POINTS: Question Can commercial LLMs accurately assign cancer stage based on descriptive MRI reports to overcome the lack of specialised expertise in clinical practice? Findings Tested LLMs demonstrated variable performances, ranging 54.8-76.0% for T-categorisation, 63.5-88.5% for N-categorisation and 53.8-80.8% for overall stage, and failed to consistently outperform MDT members. Critical relevance statement Variable tested LLM performance in staging OCC from descriptive MRI reports suggested that they are not suitable as standalone staging tools. MDT members' low performances highlight that structured MRI reports with clinical cancer staging are needed to improve multidisciplinary assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.